Skip to content

Study reveals potential challenges for scaling up of HCV therapy in UK

Grazoprevir/elbasvir shows high hepatitis C cure rate for people who inject drugs

Gregory Dore, presenting at AASLD 2015. Photo by Liz Highleyman, hivandhepatitis.com

How do we maximise global HIV treatment access? IAPAC Care Continuum Guidelines make recommendations

Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs

Conference delegates protest against the unaffordability of hepatitis C treatment. Photograph © 2015 Ahmad Yusni/Harm Reduction International.

Harm reduction conference calls for political leadership to reform drugs policy

Conference delegates show their support for the UNODC statement on drug decriminalisation. Photograph © 2015 Ahmad Yusni/Harm Reduction International.

Needle and syringe exchanges need to adapt to meet the needs of people who inject steroids and image-enhancing drugs

Image from presentation by John Campbell, at IHRC 2015.

Why is injecting equipment re-used? Drug users do their own research to find out

Dr Angella Duvnjak at IHRC 2015. Photograph © 2015 Ahmad Yusni/Harm Reduction International.

Peer workers improve drug users’ engagement with HIV care in Ukraine

Pavlo Smyrnov at IHRC 2015. Photograph © 2015 Ahmad Yusni/Harm Reduction International.

Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs